Drug intelligence / Profile preview

NuPathways MV

Development stage
Unknown
Lead developer
Nupathways
Modality
Small Molecules
Administration
Oral
01

Overview

NuPathways MV is a comprehensive, iron-free multi-vitamin and mineral supplement developed by NuPathways. Formulated as a capsule, it is designed to provide a broad spectrum of essential micronutrients, including vitamins A, C, D3, E, K1, and a full B-complex (thiamine, riboflavin, niacin, B6, folate, B12, biotin, and pantothenic acid), alongside key minerals such as magnesium, zinc, selenium, copper, manganese, chromium, molybdenum, and potassium. The "iron-free" designation makes it specifically suitable for individuals who obtain sufficient iron from their diet or those with medical conditions, such as hemochromatosis, where supplemental iron is contraindicated. The supplement functions by providing necessary cofactors for metabolic enzymes and ligands for nuclear receptors, thereby supporting overall physiological homeostasis, immune function, and the prevention of nutritional deficiencies.

Brand names
NuPathways MVNuPathways MV Capsule Formula
Other names
Iron Free Multi-Vitamin
02

Targets

RAR (Retinoic acid receptor)THR (Thyroid hormone receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on NuPathways MV.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NuPathways MV.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call